-
BioIVT Named Service Provider for Promega Immunotherapy Bioassays
May 29, 2019, 09:46 AM by Michael CroftWESTBURY, NY - May 29, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology researchFull story -
BOC Sciences Continues to Broaden Its Inhibitor Range for Researchers
May 29, 2019, 01:39 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 29, 2019 - As one of the world's leading chemical suppliers, BOC Sciences announces to continuously broaden its small molecule inhibitor range in response to an increasingly urgent need to find a cure for some major diseases that are inflicting the human beingsFull story -
Creative Proteomics Has Announced a Wide Range of Newly-developed Protein Identification Services and Peptides Analysis Services
May 28, 2019, 23:22 PM by Michael CroftSHIRLEY, NY - May 29, 2019 - SHIRLEY, NY – May 29, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently upgraded its protein identification and peptides analysis services to researchersFull story -
Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference
May 28, 2019, 09:06 AM by Michael CroftPITTSBURGH, PA, UNITED STATES - May 24, 2019 - Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the companys lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, FloridaFull story -
Certara Introduces Integral, its Next-generation Data Repository
May 28, 2019, 08:11 AM by Michael CroftPRINCETON, NJ - May 28, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the introduction of Certara Integral, its next-generation data repository for collecting, managing, and storing multiple types of data sets for analysis, sharing and reporting of clinical pharmacology, pharmacometrics and other relevant clinical dataFull story -
Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data
May 28, 2019, 05:12 AM by Michael CroftMILFORD, MA, US - May 25, 2019 -Full story- TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system
- Significant increase in diuresis, net negative fluid balance, improvement of kidney function and improvement in clinical symptoms
- Significant drop in CVP while systolic BP remained stable
-
Creative Diagnostics Launches IHC/Pathology Antibodies for Research
May 28, 2019, 02:42 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 28, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced it has launched a series of IHC/Pathology antibodies for research useFull story -
CanDIG to be part of new Canadian Digital Health and Discovery Platform
May 27, 2019, 14:03 PM by Michael CroftMONTRÉAL, QC, CANADA - May 27, 2019 - Today, Minister Navdeep Bains announced funding for the Digital Health and Discovery Platform (DHDP) through the health and biosciences stream of the Strategic Innovation FundFull story -
Creative Proteomics Upgrades a Wide Range of Newly-developed Protein Identification Services and Peptides Analysis Services
May 25, 2019, 03:45 AM by Michael CroftSHIRLEY, NY - May 25, 2019 - SHIRLEY, NY – May 25, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently upgraded its protein identification and peptides analysis services to researchersFull story -
Cala Health Raises $50 Million Series C Funding
May 23, 2019, 18:56 PM by Michael CroftBURLINGAME, CA, UNITED STATES - May 21, 2019 - Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announced it has completed a $50 million Series C financingFull story -
PROMINENT TECHNOLOGIST WILLIAM F. (BILL) STASIOR JOINS AVELLINO LABS EXECUTIVE ADVISORY COMMITTEE
May 23, 2019, 16:36 PM by Michael CroftMENLO PARK, CA - May 23, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced today the addition of William FFull story -
Exploring The Species Near Us
May 23, 2019, 07:30 AM by Michael CroftFull storyBio-IT World | Rob Dunn, Professor of Applied Ecology, North Carolina State University has written an engaging and absorbing account of his adventures in ecology, starting with field work in the remote rain forests of Costa Rica. Eventually he learned he could discover closer to home—and help students identify—previously unknown bacteria and insects in houses, including those living in showerheads and extremophiles living in freezers and ovens.
-
TTS Pharma Limited announces closing of £10.3 million fundraising and new board appointment
May 23, 2019, 04:48 AM by Michael CroftLONDON AND LIVERPOOL, UK - May 23, 2019 -Full story- The completion of series B fundraise of £10.3 million
- The appointment of Paul Atherton as Chairman
-
CD Genomics Announces Highly Accurate and Sensitive Genome Sequencing Services for Conducting a Genome-wide Analysis
May 22, 2019, 23:39 PM by Michael CroftSHIRLEY, NY, UNITED STATES - May 22, 2019 - SHIRLEY, NY, UNITED STATES – May 23, 2019 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the technical escalation of its sequencing services, The updated or newly-developed service ranges include three: nanopore sequencing, mitochondrial genome sequencing, and whole plasmid sequencing, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivityFull story -
Adimab Team Accuses Prominent MIT Investigator Of Ripping Off Antibodies, Presenting Them As His Own
May 22, 2019, 08:55 AM by Michael CroftFull storyEndpoints News | In an opinion paper published yesterday, John Carroll at Endpoints News speaks with Adimab chief Tillman Gerngross and MIT investigator Ram Sasisekharan about Gerngross's recent allegations against Sasisekharan, claiming he has been ripping off the work of others in the antibody field and passing it off as his own design done in silico.
-
Central Pharma partners with Veratrak to digitise supply chain operations
May 22, 2019, 07:52 AM by Michael CroftLONDON, UK - May 22, 2019 - Veratrak, a UK-based software provider dedicated to transforming supply chains across the life science industry, has announced that contract packaging organisation (CPO) Central Pharma has selected its platform to help it achieve digitised end-to-end visibility of its supply chain and improve collaborationFull story -
Creative Biolabs Scholarship Worth $1,000 Available to Global College Students
May 22, 2019, 06:13 AM by Michael CroftSHIRLEY, NY - May 22, 2019 - Creative Biolabs, a leading custom service provider in antibody production and engineering, launched its annual scholarship program, intended to subsidize worldwide college students with their research or further education in the biology or chemistry related fieldsFull story -
Mercia invests £2.0 million in transdermal drug delivery specialist, Medherant
May 21, 2019, 10:45 AM by Michael CroftCOVENTRY, UK - May 21, 2019 - Medherant Limited (Medherant), the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch® technology, has today announced a new £2 million investmentFull story -
UKI2S and Innovate UK launch new £10m initiative to accelerate growth of early stage science and engineering companies
May 21, 2019, 06:08 AM by Michael CroftLONDON, UK - May 21, 2019 - The £27m UK Innovation & Science Seed Fund (UKI2S) and Innovate UK (IUK) have launched a joint initiative, the UKI2S Innovate AcceleratorFull story -
WCG to Lead Educational Session on Implementing the Revised Common Rule at AAHRPP Annual Conference
May 20, 2019, 11:30 AM by Michael CroftPRINCETON, NJ - May 20, 2019 - The WIRB-Copernicus Group® (WCG) announced today that David Borasky, MPH, CIP, its vice president, IRB Compliance will be leading an educational session on the revised Common Rule at the Association for the Accreditation of Human Research Protection Programs, IncFull story